Medline Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $MDLN in the last 7 days.
No SEC Form 4 filings for $MDLN in the last 30 days.
See all $MDLN insider activity →Medline (Nasdaq: MDLN) announced a new Prime Vendor agreement with Mercy Regional Medical Center. The deal provides access to Medline's medical-surgical products and distribution capabilities. Mercy Regional cited Medline's supply chain resilience and customer service as key factors in the selection.
Medline Inc. (MDLN) shares rose 3.2% after announcing new customer wins, including expanded agreements with Stillwater Medical Center and Ohio County Healthcare. The company reported 11.6% sales growth in Q2 but lowered full-year EBITDA guidance. Analysts have mixed price targets, with a median of $53.0. Insider trading shows mostly sales, while hedge funds have varied positions.
Medline (MDLN) signed an expanded Prime Vendor agreement with Stillwater Medical Center, adding lab products to its existing medical-surgical supply contract. The deal aims to streamline ordering and improve delivery of medical supplies. Both parties highlighted the long-term partnership and benefits for patient care.
Recent MDLN coverage spans financial news, market movers and regulation.
The contract expands Medline's supply chain footprint in Louisiana.
The new contracts suggest continued revenue momentum and may support a short‑term bounce in the stock.
The new contract could boost Medline's revenue from lab supplies and strengthen its relationship with the hospital network.
The FDA issued a Class I recall for certain Medline convenience kits with B. Braun components, which contain recalled Huons Bupivacaine Hydrochloride. B. Braun reported 35 serious injuries, while Medline reported none. The recall is effective as of June 19, according to the FDA.
The filing is a large insider sale by a 10% owner, which can modestly pressure sentiment but is not a fundamental change by itself.
AlphAI scores every news story that mentions MDLN with an AI model for sentiment and relevance, and aggregates insider trades from Medline Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Medline (Nasdaq: MDLN) announced a new Prime Vendor agreement with Mercy Regional Medical Center. The deal provides access to Medline's medical-surgical products and distribution capabilities. Mercy Regional cited Medline's supply chain resilience and customer service as key factors in the selection.
1 min readMedline Inc. (MDLN) shares rose 3.2% after announcing new customer wins, including expanded agreements with Stillwater Medical Center and Ohio County Healthcare. The company reported 11.6% sales growth in Q2 but lowered full-year EBITDA guidance. Analysts have mixed price targets, with a median of $53.0. Insider trading shows mostly sales, while hedge funds have varied positions.
2 min readMedline (MDLN) signed an expanded Prime Vendor agreement with Stillwater Medical Center, adding lab products to its existing medical-surgical supply contract. The deal aims to streamline ordering and improve delivery of medical supplies. Both parties highlighted the long-term partnership and benefits for patient care.
1 min readThe FDA issued a Class I recall for certain Medline convenience kits with B. Braun components, which contain recalled Huons Bupivacaine Hydrochloride. B. Braun reported 35 serious injuries, while Medline reported none. The recall is effective as of June 19, according to the FDA.
1 min readGIC Private Ltd sold 1,600,000 shares of Medline Inc. (MDLN) at $35.80 ($57.28M total) across 2 trades over 2026-08-13 to 2026-08-14. Filed jointly with GIC Special Investments Pte Ltd (10% owner) and Hux Investment Pte. Ltd. (10% owner).
2 min readMedline reported Q2 sales up 11.6% to $7.685B and net income down 58.3% to $139M, citing $336M fire-related losses tied to its Tracy, California distribution center. For 1H 2026, sales rose 11.1% to $15.037B. Medline said it signed over $650M in new customer business and is adding distribution centers, automation, and workers, including California capacity expansion to about 5M sq ft by mid-2027.
6 min readMedline (MDLN) Q2 2026 call said adjusted EBITDA rose 13% YoY to $1.1B, with higher costs partly offset by a $243M IEEPA tariff refund benefit. Q2 net sales grew 12% to $7.7B. Company raised fiscal 2026 organic sales outlook, but moderated adjusted EBITDA outlook citing Middle East conflict, Tracy warehouse fire, investments, quality remediation, and retail softness.
7 min readMedline said regulatory guidance followed its corrective actions for surgical convenience kits whose components were affected by a Becton Dickinson recall. The alert cites BD lot 4032183 ChloraPrep Clear 1 mL and lot 4073005 FREPP Clear 1.5 mL applicators, with compromised sterile seals and possible Aspergillus contamination. Medline reported no severe injuries or deaths as of Aug 3. MDLN shares were $35.71, up 0.61%.
4 min readGIC Private Ltd sold 590,284 shares of Medline Inc. (MDLN) at $35.58 ($21.00M total) on 2026-08-07.
2 min readMedline Inc. (MDLN) disclosed in a Schedule 13G/A that Blackstone-affiliated entities and Stephen A. Schwarzman may be deemed to beneficially own 153,327,675 Class A shares, or 16.5% of the class, as of June 30, 2026. The filing cites 875,111,752 Class A shares outstanding as of May 28, 2026, held via multiple “Mozart” vehicles and related structures.
4 min read
